TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 15.31%-17.61M | ---- | 51.13%-20.79M | ---- | -0.72%-42.54M | ---- | 30.00%-42.23M | ---- | -58.58%-60.33M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -2,750.00%-171K | ---- | -500.00%-6K | ---- | 80.00%-1K | ---- | 68.75%-5K | ---- | 68.58%-16K |
Dividend (income)- adjustment | ---- | -157.14%-144K | ---- | -24.44%-56K | ---- | ---45K | ---- | ---- | ---- | -5.72%-101K |
Attributable subsidiary (profit) loss | ---- | ---4.17M | ---- | ---- | ---- | -79.31%96K | ---- | -64.39%464K | ---- | 2,490.87%1.3M |
Impairment and provisions: | ---- | -15.24%3.82M | ---- | -80.13%4.51M | ---- | -13.14%22.7M | ---- | -37.65%26.13M | ---- | 148.20%41.9M |
-Impairment of trade receivables (reversal) | ---- | -83.86%67K | ---- | -87.64%415K | ---- | 115.61%3.36M | ---- | -69.49%1.56M | ---- | 24.61%5.1M |
-Impairment of goodwill | ---- | ---- | ---- | --1.12M | ---- | ---- | ---- | ---- | ---- | 405.81%2.44M |
-Other impairments and provisions | ---- | 26.05%3.76M | ---- | -84.60%2.98M | ---- | -21.29%19.34M | ---- | -28.50%24.57M | ---- | 179.25%34.36M |
Revaluation surplus: | ---- | ---233K | ---- | ---- | ---- | -338.02%-288K | ---- | --121K | ---- | ---- |
-Other fair value changes | ---- | ---233K | ---- | ---- | ---- | -338.02%-288K | ---- | --121K | ---- | ---- |
Asset sale loss (gain): | ---- | -1,117.48%-1.05M | ---- | 138.43%103K | ---- | -206.77%-268K | ---- | -23.48%251K | ---- | -92.10%328K |
-Loss (gain) from sale of subsidiary company | ---- | ---448K | ---- | ---- | ---- | 32.46%-154K | ---- | ---228K | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | -4,900.00%-600K | ---- | 89.47%-12K | ---- | -11,500.00%-114K | ---- | -95.24%1K | ---- | -97.97%21K |
-Loss (gain) from selling other assets | ---- | ---- | ---- | --115K | ---- | ---- | ---- | 55.70%478K | ---- | -90.16%307K |
Depreciation and amortization: | ---- | -15.02%2.43M | ---- | 0.85%2.86M | ---- | -17.22%2.83M | ---- | -1.95%3.42M | ---- | 115.40%3.49M |
Financial expense | ---- | 5.13%1.89M | ---- | -61.65%1.79M | ---- | -7.70%4.68M | ---- | 19.57%5.07M | ---- | 194.27%4.24M |
Special items | ---- | --4.3M | ---- | ---- | ---- | -93.04%64K | ---- | 256.03%919K | ---- | -242.00%-589K |
Operating profit before the change of operating capital | ---- | 5.59%-10.94M | ---- | 9.31%-11.59M | ---- | -117.70%-12.78M | ---- | 39.99%-5.87M | ---- | -1.60%-9.78M |
Change of operating capital | ||||||||||
Accounts receivable (increase)decrease | ---- | 733.70%10.81M | ---- | 65.83%-1.71M | ---- | -149.43%-4.99M | ---- | 270.61%10.1M | ---- | -2,408.31%-5.92M |
Accounts payable increase (decrease) | ---- | -57.13%4.18M | ---- | 2,666.48%9.74M | ---- | 102.66%352K | ---- | -147.51%-13.25M | ---- | -135.02%-5.35M |
Special items for working capital changes | ---- | 78.74%-3.11M | ---- | -309.60%-14.63M | ---- | -3.31%6.98M | ---- | -39.39%7.22M | ---- | 132.61%11.91M |
Cash from business operations | -209.62%-14.13M | 105.14%934K | 70.61%-4.56M | -74.20%-18.19M | ---15.52M | -481.29%-10.44M | ---- | 80.36%-1.8M | ---- | 70.13%-9.15M |
Other taxs | ---- | -120.95%-88K | ---- | --420K | ---- | ---- | ---- | --300K | ---- | ---- |
Special items of business | ---- | ---- | ---- | ---- | ---- | ---- | -1,064.54%-12.11M | ---- | 107.80%1.26M | ---- |
Net cash from operations | -209.62%-14.13M | 104.76%846K | 70.61%-4.56M | -70.18%-17.77M | -28.21%-15.52M | -597.86%-10.44M | -1,064.54%-12.11M | 83.64%-1.5M | 107.80%1.26M | 71.25%-9.15M |
Cash flow from investment activities | ||||||||||
Interest received - investment | --120K | 2,750.00%171K | ---- | 500.00%6K | ---- | -80.00%1K | ---- | -68.75%5K | -44.44%5K | -68.58%16K |
Dividend received - investment | 341.18%300K | 157.14%144K | 83.78%68K | 24.44%56K | 19.35%37K | --45K | --31K | ---- | ---- | 2,480,520.16%3.2M |
Loan receivable (increase) decrease | ---- | ---4.5M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Sale of fixed assets | ---- | 118.18%600K | --600K | -58.33%275K | ---- | --660K | --660K | ---- | ---- | ---- |
Purchase of fixed assets | 90.86%-138K | 96.12%-44K | -1,913.33%-1.51M | -2.63%-1.13M | 92.84%-75K | 3.66%-1.1M | ---1.05M | -102.12%-1.15M | ---- | -133.45%-567K |
Sale of subsidiaries | ---- | --448K | --448K | ---- | ---- | --5.19M | ---10K | ---- | ---- | ---- |
Acquisition of subsidiaries | -214.74%-327K | ---- | 552.38%285K | 78.79%-63K | ---63K | ---297K | ---- | --0 | --1.44M | ---- |
Recovery of cash from investments | --16.08M | ---- | ---- | --541K | --541K | ---- | ---- | -72.42%1.01M | -72.42%1.01M | -68.19%3.67M |
Cash on investment | ---18.22M | ---8.91M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 87.67%-1.57M |
Net cash from investment operations | -1,900.00%-2.18M | -3,700.94%-12.09M | -124.77%-109K | -107.07%-318K | 219.89%440K | 3,584.50%4.5M | -114.96%-367K | -102.72%-129K | -50.07%2.45M | 539.07%4.74M |
Net cash before financing | -249.07%-16.31M | 37.84%-11.24M | 69.03%-4.67M | -204.21%-18.09M | -20.91%-15.08M | -265.85%-5.95M | -436.35%-12.47M | 63.08%-1.63M | 133.18%3.71M | 86.62%-4.4M |
Cash flow from financing activities | ||||||||||
New borrowing | -65.71%540K | 9.10%3.78M | --1.58M | --3.46M | ---- | ---- | ---- | -92.31%700K | -92.31%700K | 30.00%9.1M |
Refund | 32.43%-1.5M | -23.29%-4.14M | ---2.22M | -110.66%-3.36M | ---- | ---1.59M | ---- | ---- | ---- | ---600K |
Issuing shares | ---- | 37.64%4.94M | --4.94M | -95.06%3.59M | ---- | 1,059.77%72.65M | --688K | --6.26M | ---- | ---- |
Issuance of bonds | ---- | 7,016.33%21.35M | ---- | --300K | ---- | ---- | ---- | ---- | ---- | ---- |
Interest paid - financing | -100.00%-16K | 61.82%-247K | 74.19%-8K | 91.03%-647K | 34.04%-31K | -8,389.41%-7.22M | 17.54%-47K | 86.29%-85K | ---57K | -399.22%-620K |
Issuance expenses and redemption of securities expenses | ---- | -214.56%-324K | ---- | 99.81%-103K | ---- | -486,672.73%-53.55M | ---- | ---11K | ---11K | ---- |
Other items of the financing business | --764K | -8.87%1.37M | ---- | --1.5M | ---- | ---- | ---- | ---- | ---- | ---- |
Net cash from financing operations | -115.07%-496K | 761.36%25.21M | 607.09%3.29M | -66.21%2.93M | -293.33%-649K | 105.36%8.66M | 75.70%-165K | -26.94%4.22M | -107.99%-679K | 231.98%5.77M |
Effect of rate | ---2K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net Cash | -1,117.46%-16.8M | 192.17%13.97M | 91.23%-1.38M | -657.89%-15.16M | -24.47%-15.73M | 4.78%2.72M | -517.20%-12.64M | 88.99%2.59M | 213.23%3.03M | 103.68%1.37M |
Begining period cash | 114.47%26.18M | -55.40%12.21M | -55.40%12.21M | 11.02%27.36M | 11.02%27.36M | 11.76%24.65M | 11.76%24.65M | 6.63%22.05M | 6.63%22.05M | -64.31%20.68M |
Cash at the end | -13.41%9.37M | 114.47%26.18M | -6.95%10.83M | -55.40%12.21M | -3.12%11.63M | 11.02%27.36M | -52.12%12.01M | 11.76%24.65M | 39.30%25.08M | 6.64%22.05M |
Cash balance analysis | ||||||||||
Cash and bank balance | -13.41%9.37M | 114.47%26.18M | --10.83M | -55.40%12.21M | ---- | 11.02%27.36M | ---- | --24.65M | ---- | ---- |
Cash and cash equivalent balance | -13.41%9.37M | 114.47%26.18M | --10.83M | -55.40%12.21M | ---- | 11.02%27.36M | ---- | --24.65M | ---- | ---- |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Zhongzheng Tianheng Certified Public Accountants Co., Ltd. | -- | Zhongzheng Tianheng Certified Public Accountants Co., Ltd. | -- | Zhongzheng Tianheng Certified Public Accountants Co., Ltd. | -- | Zhongzheng Tianheng Certified Public Accountants Co., Ltd. | -- | Zhongzheng Tianheng Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.